inadvertently discovered that hepatocyte growth factor (HGF) enhances GD2 expression on the surface of Ewing sarcoma cells and achieves unexpected anti-tumor effects when combined with GD2-CAR-T cells for the treatment of Ewing sarcoma (56). Here, HGF is linked to neoplasm.